Low C-peptide reflects reduced endogenous insulin production — classically type 1 diabetes and LADA (autoimmune beta-cell destruction), and late-stage type 2 diabetes with beta-cell exhaustion.
Other causes: exogenous insulin therapy suppressing pancreatic secretion, pancreatectomy or pancreatic damage, and prolonged fasting or low food intake.
High C-peptide reflects excess endogenous insulin production — most often the compensatory hyperinsulinemia of insulin resistance seen in obesity, metabolic syndrome, and early type 2 diabetes.
Other causes: insulinoma (insulin-secreting tumor), Cushing's syndrome, insulin-stimulating drugs such as sulfonylureas, and reduced renal clearance in kidney insufficiency.
Provides a comprehensive metabolic assessment of blood glucose control using a static multi-biomarker approach.
View Full Analysis100% free and private. Enter only the values you have.
About the site author
My personal mission is to extend human lifespan by collectively adding 1 million years to people's lives.
That’s why I made this site 100% free, no sign-up, no email. Just instant results.
Zsolt SzaboPrecision Health Consultant for Longevity Clinics